Veracyte (VCYT) Jumps: Stock Rises 8.3% - Tale of the Tape

Veracyte, Inc. VCYT was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 28% since Mar 3.

This medical instrument company has seen one negative estimate revision over the last 30 days and its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Veracyte has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Cynosure, Inc. CYNO, Syneron Medical Ltd. ELOS and Natus Medical Inc. BABY. While Cynosure and Syneron Medical hold a Zacks Rank #1 (Strong Buy), Natus Medical carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

NATUS MEDICAL BABY: Free Stock Analysis Report

CYNOSURE INC-A CYNO: Free Stock Analysis Report

SYNERON MED LTD ELOS: Free Stock Analysis Report

VERACYTE INC VCYT: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs